Modelling the strategic use of antiretroviral therapy for the treatment and prevention of HIV.

Abstract:

:Nathan Ford and Gottfried Hirnschall reflect on recent research by Jan Hontelez and colleagues published in this week's PLOS Medicine. The authors argue that the future HIV modeling efforts should focus on helping programs make choices about which interventions need to be prioritized in order to achieve the levels of enrollment and retention in care required to maximize the prevention benefit of ART. Please see later in the article for the Editors' Summary.

journal_name

PLoS Med

journal_title

PLoS medicine

authors

Ford N,Hirnschall G

doi

10.1371/journal.pmed.1001535

subject

Has Abstract

pub_date

2013-10-01 00:00:00

pages

e1001535

issue

10

eissn

1549-1277

issn

1549-1676

pii

PMEDICINE-D-13-02856

journal_volume

10

pub_type

评论,杂志文章